Last Updated : December 7, 2023
Details
Review Type: Panel
Details
Canada's Drug Agency Program Updates
- Drug Reimbursement Reviews for COVID-19 Drugs
Last Updated : July 27, 2023
Details
| Call for patient/clinician input open | July 20, 2023 |
|---|---|
| Call for patient/clinician input closed | September 11, 2023 |
| Clarification: - Patient input submission received from Myeloma Canada | |
| Submission received | August 31, 2023 |
| Submission accepted | October 04, 2023 |
| Clarification: - Submission was not accepted for review on 15 Sep 23 | |
| Review initiated | October 05, 2023 |
| Draft Canada's Drug Agency review report(s) provided to sponsor for comment | December 20, 2023 |
| Deadline for sponsors comments | January 08, 2024 |
| Canada's Drug Agency review report(s) and responses to comments provided to sponsor | February 02, 2024 |
| Expert committee meeting (initial) | February 14, 2024 |
| Draft recommendation issued to sponsor | February 28, 2024 |
| Draft recommendation posted for stakeholder feedback | March 07, 2024 |
| End of feedback period | March 22, 2024 |
| Final recommendation issued to sponsor and drug plans | April 08, 2024 |
| Final recommendation posted | April 24, 2024 |
| Deadline for sponsor to submit redaction requests on draft Canada's Drug Agency review report(s) | April 22, 2024 |
| Canada's Drug Agency review report(s) posted | September 11, 2024 |
Last Updated : September 12, 2024
Details
| Call for patient/clinician input open | 13-Jul-23 |
|---|---|
| Call for patient/clinician input closed | 01-Sep-23 |
| Clarification: - Patient input submission received from Colorectal Cancer Canada and Colorectal Cancer Resource & Action Network (CCRAN) | |
| Call for industry input open | 13-Jul-23 |
| Call for industry input closed | 01-Sep-23 |
| Submission received | 19-May-23 |
| Review initiated | 18-Jul-23 |
| Expert committee meeting (initial) | 01-Feb-24 |
| Draft recommendation posted for stakeholder feedback | 28-Feb-24 |
| End of feedback period | 13-Mar-24 |
| Final recommendation posted | 18-Apr-24 |
| CADTH review report(s) posted | 29-Jul-24 |
Last Updated : February 10, 2025
Details
| Call for patient/clinician input open | July 12, 2023 |
|---|---|
| Call for patient/clinician input closed | September 01, 2023 |
| Call for industry input open | July 13, 2023 |
| Call for industry input closed | September 01, 2023 |
| Submission received | July 06, 2023 |
| Clarification: - Patient input submission received from TSC Canada | |
| Review initiated | July 18, 2023 |
| Expert committee meeting (initial) | February 01, 2024 |
| Draft recommendation posted for stakeholder feedback | February 15, 2024 |
| End of feedback period | March 01, 2024 |
| Final recommendation posted | May 16, 2024 |
| Canada's Drug Agency review report(s) posted | January 22, 2024 |
Last Updated : October 30, 2024
Details
| Call for patient/clinician input open | July 07, 2023 |
|---|---|
| Call for patient/clinician input closed | September 01, 2023 |
| Clarification: - Patient input submission received from Fighting Blindness Canada, The Cdn Council of the Blind, CNIB, Vision Loss Rehabilitation Canada, International Federation on Ageing, International Federation on Ageing (IFA) and Diabetic macular edema | |
| Submission received | August 18, 2023 |
| Submission accepted | September 05, 2023 |
| Clarification: - Submission was not accepted for review on 01 Sep 2023 | |
| Review initiated | September 06, 2023 |
| Draft CADTH review report(s) provided to sponsor for comment | November 30, 2023 |
| Deadline for sponsors comments | December 11, 2023 |
| CADTH review report(s) and responses to comments provided to sponsor | January 12, 2024 |
| Expert committee meeting (initial) | January 24, 2024 |
| Draft recommendation issued to sponsor | February 08, 2024 |
| Draft recommendation posted for stakeholder feedback | February 15, 2024 |
| End of feedback period | March 01, 2024 |
| Clarification: - Reconsideration: minor revisions requested by sponsor - Request for minor reconsideration not accepted - Reconsideration: major revisions requested by sponsor | |
| Expert committee meeting | May 22, 2024 |
| Final recommendation issued to sponsor and drug plans | June 05, 2024 |
| Final recommendation posted | June 21, 2024 |
| Deadline for sponsor to submit redaction requests on draft CADTH review report(s) | June 19, 2024 |
| CADTH review report(s) posted | November 21, 2024 |
Last Updated : February 10, 2025
Details
| Call for patient/clinician input open | 07-Jul-23 |
|---|---|
| Call for patient/clinician input closed | 01-Sep-23 |
| Clarification: - Patient input submission received from MS Canada and The Sumaira Foundation | |
| Submission received | 18-Aug-23 |
| Submission accepted | 01-Sep-23 |
| Review initiated | 05-Sep-23 |
| Draft Canada's Drug Agency review report(s) provided to sponsor for comment | 21-Nov-23 |
| Deadline for sponsors comments | 30-Nov-23 |
| Canada's Drug Agency review report(s) and responses to comments provided to sponsor | 12-Jan-24 |
| Expert committee meeting (initial) | 24-Jan-24 |
| Draft recommendation issued to sponsor | 06-Feb-24 |
| Draft recommendation posted for stakeholder feedback | 15-Feb-24 |
| End of feedback period | 01-Mar-24 |
| Final recommendation issued to sponsor and drug plans | 13-Mar-24 |
| Final recommendation posted | 02-Apr-24 |
| Deadline for sponsor to submit redaction requests on draft Canada's Drug Agency review report(s) | 28-Mar-24 |
| Canada's Drug Agency review report(s) posted | 23-Jul-24 |
Last Updated : July 23, 2024
Details
| Call for patient/clinician input open | 07-Jul-23 |
|---|---|
| Call for patient/clinician input closed | 01-Sep-23 |
| Clarification: - Patient input submission received from Fighting Blindness Canada, The Canadian Council of the Blind, CNIB, Vision Loss Rehabilitation Canada, International Federation on Ageing and the Canadian Council of the Blind | |
| Submission received | 18-Aug-23 |
| Submission accepted | 05-Sep-23 |
| Clarification: - Submission was not accepted for review on 01 Sep 2023 | |
| Review initiated | 06-Sep-23 |
| Draft Canada's Drug Agency review report(s) provided to sponsor for comment | 30-Nov-23 |
| Deadline for sponsors comments | 11-Dec-23 |
| Canada's Drug Agency review report(s) and responses to comments provided to sponsor | 12-Jan-24 |
| Expert committee meeting (initial) | 24-Jan-24 |
| Draft recommendation issued to sponsor | 08-Feb-24 |
| Draft recommendation posted for stakeholder feedback | 15-Feb-24 |
| End of feedback period | 01-Mar-24 |
| Clarification: - Reconsideration: major revisions requested by sponsor | |
| Expert committee meeting | 22-May-24 |
| Final recommendation issued to sponsor and drug plans | 05-Jun-24 |
| Final recommendation posted | 21-Jun-24 |
| Deadline for sponsor to submit redaction requests on draft Canada's Drug Agency review report(s) | 19-Jun-24 |
| Canada's Drug Agency review report(s) posted | 07-Nov-24 |
Last Updated : November 7, 2024
Details
| Call for patient/clinician input open | July 04, 2023 |
|---|---|
| Call for patient/clinician input closed | August 25, 2023 |
| Clarification: - Patient input submission received from Colorectal Cancer Canada, and Colorectal Cancer Resource & Action Network (CCRAN) | |
| Submission received | August 15, 2023 |
| Submission accepted | August 29, 2023 |
| Review initiated | August 30, 2023 |
| Draft CADTH review report(s) provided to sponsor for comment | November 16, 2023 |
| Deadline for sponsors comments | November 27, 2023 |
| CADTH review report(s) and responses to comments provided to sponsor | December 21, 2023 |
| Expert committee meeting (initial) | January 10, 2024 |
| Draft recommendation issued to sponsor | January 23, 2024 |
| Draft recommendation posted for stakeholder feedback | February 01, 2024 |
| End of feedback period | February 15, 2024 |
| Final recommendation issued to sponsor and drug plans | February 29, 2024 |
| Final recommendation posted | March 19, 2024 |
| Deadline for sponsor to submit redaction requests on draft CADTH review report(s) | March 14, 2024 |
| CADTH review report(s) posted | June 14, 2024 |
Last Updated : March 3, 2025
Details
| Call for patient/clinician input open | 04-Jul-23 |
|---|---|
| Call for patient/clinician input closed | 25-Aug-23 |
| Submission received | 15-Aug-23 |
| Submission accepted | 29-Aug-23 |
| Review initiated | 30-Aug-23 |
| Clarification: - Submission temporarily suspended -Voluntarily withdrawn by the sponsor on 26 Sep 2023 | |
Last Updated : September 27, 2023